Twist Bioscience Corp (TWST): Amount of Long-Term Liabilities

Symbol and logo of brand Twist Bioscience Corp (TWST)

Operating losses stemming from production expansion are weighing on the finances of Twist Bioscience (TWST), where long-term debt stands at 0.08. Under Emily Lepruest's leadership, the company is aggressively penetrating data storage markets, converting its technological breakthrough into revenue. Current price action on GURU.Markets confirms the status of the DNA synthesis leader, whose growing demand and margins are steering the company toward a stable cash flow.

TWST Twist Bioscience, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Metric breakdowns and analytics for Twist Bio (TWST)

- price and consensus price forecast:
Stock Price twistbioscience.com|TWST - Consensus Target
- market capitalization data:
Market Value Twist Bioscience|TWST - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value per Share Twist Bioscience|TWST - Book Capitalization|Market Capitalization to Book Value twistbioscience.com|TWST - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Twist Bioscience|TWST - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Twist Bioscience Corp|TWST - Company Total Debt|Debt to Net Assets Ratio Twist Bioscience|TWST - Company Long-Term Debts|Company Short-Term Debt Twist Bioscience
Comprehensive company analysis:TWST (twistbioscience.com)
Mass-produced product of Twist Bioscience Inc

Long-term debt reflects the total volume of credit obligations with maturities exceeding one year, serving as an indicator of financial stability and capital structure. The current value of 0.08, combined with changes in the corporation's long-term loans and borrowings, confirms the ability of Twist Bioscience (TWST) to maintain technological dominance in DNA synthesis without excessive debt pressure, highlighting the high investment attractiveness of the business.

Competitors of Twist Bioscience (TWST)

TEM - Company Long-Term Debts|Company Long-Term Liabilities Qiagen QGEN|Ionis Pharmaceuticals, Inc. (IONS) - Amount of Long-Term Liabilities|RGEN (Repligen Corp.) - Company Long-Term Liabilities|Avidity Corp (RNA) - Company Long-Term Liabilities|CRSP: Company Long-Term Debts|Long-Term Debt Volume WGS|RARE (Ultragenyx) - Company Long-Term Debt|Long-Term Debt Volume Beam Therapeutics Inc BEAM|Company Long-Term Liabilities Sarepta Therapeutics Inc (SRPT)|TXG - Amount of Long-Term Liabilities|Company Long-Term Liabilities Intellia Therapeutics (NTLA)|STOK - Company Long-Term Loans and Borrowings|BioLife Solutions (BLFS) - Company Long-Term Debts|Wave Life Sciences Ltd (WVE) - Company Long-Term Debt|MAZE: Company Long-Term Debts|Long-Term Debt Volume SION|Prime Medicine, Inc. - Company Long-Term Debt|Long-Term Debt TSHA (tayshagtx.com)|Company Long-Term Debt QURE|Long-Term Debt Volume MeiraGTx Holdings MGTX|RGNX: Company Long-Term Debts|SLDB - Company Long-Term Liabilities|Ocugen, Inc. - Company Long-Term Debts|pacb.com (PACB) - Long-Term Debt Volume|Company Long-Term Debts BNTC (Benitec Biopharma)|Long-Term Debt DSGN|Company Long-Term Debt Rocket Pharmaceuticals Inc RCKT|Company Long-Term Indebtedness 4D Molecular Corp (FDMT)|Lexeo Therapeutics, Inc. - Company Long-Term Debts|Company Long-Term Liabilities Korro Bio Inc. KRRO|EDIT (Editas Medicine) - Company Long-Term Debts|Silence Therapeutics PLC (SLN) - Long-Term Debt|PRQR - Company Long-Term Liabilities|Amount of Long-Term Liabilities Codexis|Company Long-Term Liabilities SGMO|Company Long-Term Liabilities NAUT|MGX (Metagenomi) - Company Long-Term Debt|Long-Term Debt Volume Precision BioSciences Inc. DTIL|Company Long-Term Liabilities Generation Bio (GBIO)|Amount of Long-Term Liabilities Boundless Bio Inc BOLD|Exicure Corp (XCUR) - Company Long-Term Debts|IMNN: Company Long-Term Indebtedness|Company Long-Term Debt phiopharma.com|Mustang Bio (MBIO) - Company Long-Term Indebtedness|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Debts Bionano (BNGO)|Company Long-Term Liabilities Applied DNA Sciences|Amount of Long-Term Liabilities bluebirdbio.com BLUE|ImmunoPrecise Antibodies Ltd. - Company Long-Term Liabilities|Company Long-Term Liabilities Omega Therapeutics Inc OMGA|Company Long-Term Debts OMIC (Singular Genomics Systems Inc)|RGLS: Long-Term Debt Volume|Syros Pharmaceuticals - Company Long-Term Debt|Long-Term Debt Volume telesisbio.com|TRACON Pharmaceuticals, Inc. (TCON) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Unity Biotechnology Inc. (UBX)